Helen Thackray
Pediatrics · Washington, DCNPI 1912082025
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,961,152 of the $4,556,261 with a category attached, or 86.9%. AbbVie accounts for 87.1% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $3,975,575, more than ten times the $44,238 reported in 2020. Among pediatrics clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $126,563 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4M
- Immunogen, Inc.$544K
- Biocryst Pharmaceuticals, Inc.$44K
What the payments were for
- Speaking & faculty fees$588,15013%
- Travel & lodging$5,6520%
- Food & beverage$1,3080%
- Other$3,961,15287%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $3,968,075 |
| Immunogen, Inc. | 19 | $543,948 |
| Biocryst Pharmaceuticals, Inc. | 15 | $44,238 |
How this compares
$4,556,261 in reported general payments places this provider in the 95th percentile of 288 pediatrics providers in District of Columbia.
Other pediatrics in Washington
- Brenda MartinWashington$156K
- David NelsonWashington$71K
- Christina GrantWashington$56K
- Ariel LevyWashington$49K
- Maia McCuistonWashington$23K
- Craig SableWashington$22K
- Caroline van VleckWashington$18K
- Barbara Speller BrownWashington$16K
- Hemant SharmaWashington$13K
- Andrey OstrovskyWashington$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.